1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 230 results.

$Thumbnail for Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia$

AML - 911

Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

AML - 917

Clonal Hematopoiesis of Indeterminate Potential Mutations in Neuroendocrine Tumor Patients: Cluster Analysis and Application of Risk Scores

Harsha Pattnaik

Poster Presenter: Harsha Pattnaik

AML - 920

Beyond ELN Risk: Clinical Severity and Infections Determine Early Mortality in AML in Peru

Cesar Copaja-Corzo

Poster Presenter: Cesar Copaja-Corzo

$Thumbnail for Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis$

AML - 923

Venetoclax-Based Salvage Therapy as a Bridge to Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory AML: A Systematic Review and Meta-Analysis

Bhaswanth Bollu

Poster Presenter: Bhaswanth Bollu

Thumbnail for Phase A of the F-A-A Study: Derivation of a Bedside Functional Assessment-Age-Albumin Score for Predicting Induction Mortality in Patients With AML Receiving Low-Intensity Venetoclax-Based Therapy

AML - 927

Phase A of the F-A-A Study: Derivation of a Bedside Functional Assessment-Age-Albumin Score for Predicting Induction Mortality in Patients With AML Receiving Low-Intensity Venetoclax-Based Therapy

Rudra Narayan Swain

Poster Presenter: Rudra Narayan Swain

AML - 941

Real-World Outcomes of Acute Myeloid Leukemia, Myelodysplasia-Related: A Single Centre Study from Pakistan

Maryam Khan

Poster Presenter: Maryam Khan

Thumbnail for Survival Outcomes in Relation to EBMT Risk Score in Patients with Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Low- and Middle-Income Countries

AML - 946

Survival Outcomes in Relation to EBMT Risk Score in Patients with Hematological Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in Low- and Middle-Income Countries

Maryam Khan

Poster Presenter: Maryam Khan

AML - 947

A 25-Year Analysis of Leukemia and Hypertensive Disease Co-Mortality Among Older Adults in the United States, 1999-2024

Nuri Tamanna

Poster Presenter: Nuri Tamanna

Thumbnail for Upfront Triple Therapy With FLAG-Venetoclax Backbone in Intensive Chemotherapy-Eligible FLT3-ITD Patients With AML: Preliminary Results From a Retrospective Cohort

AML - 949

Upfront Triple Therapy With FLAG-Venetoclax Backbone in Intensive Chemotherapy-Eligible FLT3-ITD Patients With AML: Preliminary Results From a Retrospective Cohort

Mayank Soni

Poster Presenter: Mayank Soni